Research progress of CD39-CD73-adenosine pathway in immune regulation of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) patients accounts for 85%-90% of all primary liver cancer patients. Surgical treatment methods, represented by resection and liver transplantation, have relatively good efficacy and are currently the preferred treatment approaches for HCC, with a 5-year survival rate o...
Saved in:
Main Authors: | Lin SUN, Beili WANG, Wei GUO |
---|---|
Format: | Article |
Language: | English |
Published: |
Shanghai Chinese Clinical Medicine Press Co., Ltd.
2024-12-01
|
Series: | Zhongguo Linchuang Yixue |
Subjects: | |
Online Access: | https://www.c-jcm.com/article/doi/10.12025/j.issn.1008-6358.2024.20240056 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
T Cell-Derived Apoptotic Extracellular Vesicles Ameliorate Bone Loss via CD39 and CD73-Mediated ATP Hydrolysis
by: Yang X, et al.
Published: (2025-01-01) -
Altered CD73-Adenosine Signaling Linked to Infection in Patients undergoing hemodialysis
by: Xiang F, et al.
Published: (2025-01-01) -
Adenosine signaling in tumor-associated macrophages and targeting adenosine signaling for cancer therapy
by: Lei Yang, et al.
Published: (2024-11-01) -
Expression of CD39 is associated with T cell exhaustion in ovarian cancer and its blockade reverts T cell dysfunction
by: Marius Witt, et al.
Published: (2024-12-01) -
CD73 alleviates osteoarthritis by maintaining anabolism and suppressing catabolism of chondrocytes extracellular matrix
by: Hu Guo, et al.
Published: (2024-11-01)